A Utah mother is fighting for her teen daughter’s access to diabetes medicine after it was discontinued. Alison Smart, plus ...

The firm continues its fight for rights to compensation due to an alleged overpricing scheme regarding Apidra, Basglar, Fiasp, Lantus, Levemir, Novolog, Humalog and Toujeo. Those affected may contact ...

The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, ...

Sanofi SNY reported first-quarter 2024 adjusted earnings of 96 cents per American depositary share, in line with the Zacks ...

Midcap stock Sanofi India is rewarding investors with back-to-back hefty dividends. After paying dividend of Rs 50 per share ...

Two posters from the Academy of Managed Care Pharmacy (AMCP) annual meeting explore how an interchangeable insulin glargine ...

Steph's portfolio includes, amongst others, Toujeo/Diabetes where she led the brand's strategic development and successful launch; Actemra/RA where she drove KOL planning and engagement for brand ...